Vertex Pharmaceuticals Incorporated (VRTX) Institutional Ownership & Insider Trading

1,750 institutions reported holding Vertex Pharmaceuticals Incorporated shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 94 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

VRTXVertex Pharmaceuticals IncorporatedFollow VRTX — free

Biotechnology · Healthcare

—

Price chart with a free account

Market cap: 132.8B
P/E TTM: 30.5
Dividend yield: —
52-week: —
Next earnings: 2 Nov, in 9 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

1,750 institutions held 95.5% of the shares. Across filers that reported both quarters, shares held changed +0.9%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	1,750	242	+0.9%	627	142	533	83
Mar 26	1,675	232	-0.5%	570	103	519	75
Dec 25	1,627	235	-2.9%	523	137	472	71
Sep 25	1,480	238	-0.0%	478	103	532	123
Jun 25	1,529	241	+0.1%	509	71	505	113
Mar 25	1,578	236	+1.6%	537	151	477	96
Dec 24	1,506	235	-2.7%	464	67	517	130
Sep 24	1,504	231	-1.7%	524	73	482	78

Vertex Pharmaceuticals Incorporated — questions

Who owns Vertex Pharmaceuticals Incorporated stock?: 1,750 institutions reported Vertex Pharmaceuticals Incorporated shares in 13F filings for the quarter ended 2026-06-30. The largest: Capital World Investors (10.3%), BlackRock, Inc. (9.5%), Capital Research Global Investors (7.7%).
Are Vertex Pharmaceuticals Incorporated insiders buying or selling?: 94 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Vertex Pharmaceuticals Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.